MoneyWorks4Me

Hikal - Quaterly Results

08 Feb 2024 Evaluate
A decrease in the sales to Rs. 4475.70 millions was observed for the quarter ended December 2023. The sales stood at Rs. 5402.00 millions during the similar quarter previous year.Net Profit of the company move down -38.39% to Rs. 162.70  millions from Rs. 264.10 millions  in the same quarter last year.Operating profit for the quarter ended December 2023 decreased to 649.50 millions as compared to 770.90 millions of corresponding quarter ended December 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 4475.70 5402.00 -17.15 12705.00 14777.40 -14.02 20230.30 19427.20 4.13
Other Income 0.60 25.10 -97.61 19.90 70.30 -71.69 54.10 48.90 10.63
PBIDT 649.50 770.90 -15.75 1745.80 1740.10 0.33 2624.70 3454.50 -24.02
Interest 142.40 130.30 9.29 411.10 351.20 17.06 481.00 312.10 54.12
PBDT 507.10 640.60 -20.84 1334.70 1388.90 -3.90 2143.70 3142.40 -31.78
Depreciation 289.70 282.70 2.48 852.70 821.80 3.76 1090.10 956.70 13.94
PBT 217.40 357.90 -39.26 482.00 567.10 -15.01 1053.60 2185.70 -51.80
TAX 54.70 93.80 -41.68 125.50 144.00 -12.85 269.80 580.60 -53.53
Deferred Tax 3.10 -10.50 -129.52 1.70 -13.80 -112.32 -35.00 -15.90 120.13
PAT 162.70 264.10 -38.39 356.50 423.10 -15.74 783.80 1605.10 -51.17
Equity 246.60 246.60 0.00 246.60 246.60 0.00 246.60 246.60 0.00
PBIDTM(%) 14.51 14.27 1.69 13.74 11.78 16.69 12.97 17.78 -27.04
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..